title: Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells.
abstract: Epstein-Barr virus (EBV) carrying lymphoblastoid cell lines (LCLs) and EBV-positive Burkitt lymphoma (BL) cells were compared for their expression of class I antigens of the major histocompatibility complex. Five common BL lines, LCLs, pokeweed mitogen-stimulated blasts and resting B-cells from healthy donors, and eight pairs of BL cells and LCLs, each pair originating from one patient, were tested. Quantitative analysis was performed using a radioimmunoassay; qualitative aspects were studied by one- and two-dimensional gel electrophoresis. In general, LCLs expressed significantly higher amounts of class I antigens than BL cells, the latter showing class I densities similar to or lower than peripheral resting B-cells. From analysis of the expression of class I-specific RNA, there is some evidence that class I antigen expression is regulated on the transcriptional level. In two BL cells studied, class I expression could be enhanced by gamma-interferon, whereas the corresponding LCLs seemed to be refractory to this treatment. One- and two-dimensional gel electrophoresis showed that in some BL lines, in addition to the generally lower class I expression, distinct class I specificities were down-regulated. None of these alterations in class I expression was EBV specific; however, they may well play a role in the recognition of BL cells and LCLs by cellular immune mechanisms. Thus, down-regulation of class I antigens may contribute to the resistance of BL cells to cytotoxic T-lymphocytes, whereas their enhanced expression may improve the recognition of EBV-infected LCLs.
authors.affiliation: Max von Pettenkofer-Institute for Hygiene and Medical Microbiology, University of Munich, Federal Republic of Germany.
authors.forename: W
authors.initials: W
authors.lastname: Jilg
authors.forename: R
authors.initials: R
authors.lastname: Voltz
authors.forename: C
authors.initials: C
authors.lastname: Markert-Hahn
authors.forename: H
authors.initials: H
authors.lastname: Mairhofer
authors.forename: I
authors.initials: I
authors.lastname: Münz
authors.forename: H
authors.initials: H
authors.lastname: Wolf
mesh_terms: D015152:Blotting, Northern; D002051:Burkitt Lymphoma / Q000276:immunology*; D002460:Cell Line; D002472:Cell Transformation, Viral; D015180:Electrophoresis, Gel, Two-Dimensional; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D006801:Humans; D007371:Interferon-gamma / Q000494:pharmacology; D008214:Lymphocytes / Q000276:immunology* / Q000382:microbiology; D008285:Major Histocompatibility Complex; D008970:Molecular Weight; D011043:Pokeweed Mitogens / Q000494:pharmacology; D011233:Precipitin Tests; D012333:RNA, Messenger / Q000235:genetics; D014412:Tumor Virus Infections / Q000276:immunology*
chemical_list: D015395:Histocompatibility Antigens Class I; D011043:Pokeweed Mitogens; D012333:RNA, Messenger; D007371:Interferon-gamma